Compare ATRC & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATRC | ECPG |
|---|---|---|
| Founded | 2000 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.0B |
| IPO Year | 2005 | 1999 |
| Metric | ATRC | ECPG |
|---|---|---|
| Price | $59.17 | $97.64 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | $55.78 | ★ $117.00 |
| AVG Volume (30 Days) | ★ 819.5K | 177.5K |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 74.74 | ★ 287.14 |
| EPS | 0.18 | ★ 6.66 |
| Revenue | $201,630,000.00 | ★ $1,768,802,000.00 |
| Revenue This Year | $13.42 | $8.01 |
| Revenue Next Year | $12.12 | $1.42 |
| P/E Ratio | $329.67 | ★ $15.02 |
| Revenue Growth | 15.40 | ★ 34.37 |
| 52 Week Low | $25.36 | $40.52 |
| 52 Week High | $61.70 | $105.98 |
| Indicator | ATRC | ECPG |
|---|---|---|
| Relative Strength Index (RSI) | 61.37 | 45.81 |
| Support Level | $26.95 | $93.08 |
| Resistance Level | $61.70 | $103.97 |
| Average True Range (ATR) | 2.06 | 3.42 |
| MACD | 0.07 | -0.13 |
| Stochastic Oscillator | 95.08 | 18.76 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Encore Capital Group Inc is an international specialty finance company engaged in providing debt recovery solutions and other related services for consumers across a broad range of financial assets. It mainly purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals to repay their obligations and work toward financial recovery. The company also provides debt servicing and other portfolio management services to credit originators for non-performing loans in Europe. It has only one reportable segment, debt purchasing and recovery. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Europe, and other regions.